Evidence map›Paper›PMID 31656508›Full record

ArticleAfrican health sciences2019

Colour vision deficiency among students in Lagos State, Nigeria.

Olalekan A Oduntan, Khathutshelo P Mashige, Franklin E Kio

Open access · diamondAbstract read
In one paragraph

Article in African health sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Olalekan A OduntanDepartment of Optometry, School of Health Sciences, University of KwaZulu-Natal, Durban, 4000, South Africa.
Khathutshelo P MashigeDepartment of Optometry, School of Health Sciences, University of KwaZulu-Natal, Durban, 4000, South Africa.
Franklin E KioDepartment of Optometry, Faculty of Life Sciences, University of Benin, Benin City, Nigeria.
University of Benin · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCongenital colour vision defects are x-linked inherited, non-progressive and untreatable disorders that describe poor colour discrimination.

objectiveTo determine the prevalence of congenital colour vision deficiency among students in Lagos, Nigeria.

methodsA school-based cross-sectional, cluster sample study was conducted to test the colour vision of 2326 primary and high school students. Inclusion criteria were Snellen VA 20/20 or better and absence of known ocular pathologies. Colour vision deficiency (CVD) was evaluated with the Richmond-HRR colour vision test plates.

resultsThere were 1014 (43.6%) males and 1312 (56.4%) females with a mean age of 13.40 ± 2.40 years (range = 7-22 years). The prevalence of CVD was 58 (2.5%), which was higher in males 49 (4.8%) than females 9 (0.7%). The prevalence of congenital CVD was significantly associated with males (p = 0.00), but not with females (p = 0.22). Of the 58 cases of CVD, 17 (0.7%) had protan deficiency, 38 (1.6%) had deutan deficiency and three (0.1%) were unclassified.

conclusionThe prevalence of congenital CVD among students in Lagos is comparable to findings in other parts of Nigeria but differs from other parts of the country. These results strengthen the need to establish school vision screening.

Indexed as

AdolescentChildColor Vision DefectsCross-Sectional StudiesFemaleHumansMaleNigeriaPrevalenceYoung AdultColour vision deficiencyNigeriaprevalencered-green defectsRichmond-HRR

Identifiers

PMID31656508
PMCPMC6794524
OpenAlexW2969982581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.